Literature DB >> 17551598

Airflow obstruction in young adults in Canada.

Manal Al-Hazmi1, Kate Wooldrage, Nicholas R Anthonisen, Margaret R Becklake, Dennis Bowie, Moira Chan-Yeung, Helen Dimich-Ward, Pierre Ernst, Jure Manfreda, Malcolm R Sears, Hans C Siersted, Lamont Sweet, Linda Van Til.   

Abstract

OBJECTIVE: Airflow obstruction is relatively uncommon in young adults, and may indicate potential for the development of progressive disease. The objective of the present study was to enumerate and characterize airflow obstruction in a random sample of Canadians aged 20 to 44 years.
SETTING: The sample (n=2962) was drawn from six Canadian sites.
DESIGN: A prevalence study using the European Community Respiratory Health Survey protocol was conducted. Airflow obstruction was assessed by spirometry. Bronchial responsiveness, skin reactivity to allergens and total serum immunoglobulin E were also measured. Logistic regression was used for analysis.
RESULTS: Airflow obstruction was observed in 6.4% of the sample, not associated with sex or age. The risk of airflow obstruction increased in patients who had smoked and in patients who had lung trouble during childhood. Adjusted for smoking, the risk of airflow obstruction was elevated for subjects with past and current asthma, skin reactivity to allergens, elevated levels of total immunoglobulin E and bronchial hyper-responsiveness. Of the subjects with airflow obstruction, 21% were smokers with a history of asthma, 50% were smokers without asthma, 12% were nonsmokers with asthma and 17% were nonsmokers with no history of asthma. Bronchial hyper-responsiveness increased the prevalence of airflow obstruction in each of these groups.
CONCLUSION: Smoking and asthma, jointly and individually, are major determinants of obstructive disorders in young adults. Bronchial hyper-responsiveness contributes to obstruction in both groups.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17551598      PMCID: PMC2676367          DOI: 10.1155/2007/987249

Source DB:  PubMed          Journal:  Can Respir J        ISSN: 1198-2241            Impact factor:   2.409


  26 in total

1.  Spirometric reference values from a sample of the general U.S. population.

Authors:  J L Hankinson; J R Odencrantz; K B Fedan
Journal:  Am J Respir Crit Care Med       Date:  1999-01       Impact factor: 21.405

2.  Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS).

Authors: 
Journal:  Eur Respir J       Date:  1996-04       Impact factor: 16.671

Review 3.  Genetic risk factors for chronic obstructive pulmonary disease.

Authors:  A J Sandford; T D Weir; P D Paré
Journal:  Eur Respir J       Date:  1997-06       Impact factor: 16.671

4.  Prevalence of asthma symptoms among adults aged 20-44 years in Canada.

Authors:  J Manfreda; M R Becklake; M R Sears; M Chan-Yeung; H Dimich-Ward; H C Siersted; P Ernst; L Sweet; L Van Til; D M Bowie; N R Anthonisen; R B Tate
Journal:  CMAJ       Date:  2001-04-03       Impact factor: 8.262

Review 5.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

6.  Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group.

Authors:  D P Tashkin; M D Altose; J E Connett; R E Kanner; W W Lee; R A Wise
Journal:  Am J Respir Crit Care Med       Date:  1996-06       Impact factor: 21.405

7.  Variation in bronchial responsiveness in the European Community Respiratory Health Survey (ECRHS).

Authors:  S Chinn; P Burney; D Jarvis; C Luczynska
Journal:  Eur Respir J       Date:  1997-11       Impact factor: 16.671

8.  Worldwide variations in the prevalence of asthma symptoms: the International Study of Asthma and Allergies in Childhood (ISAAC)

Authors: 
Journal:  Eur Respir J       Date:  1998-08       Impact factor: 16.671

Review 9.  Respiratory health effects of exposure to environmental tobacco smoke.

Authors:  Moira Chan-Yeung; Helen Dimich-Ward
Journal:  Respirology       Date:  2003-06       Impact factor: 6.424

10.  Chronic obstructive pulmonary disease surveillance--United States, 1971-2000.

Authors:  David M Mannino; David M Homa; Lara J Akinbami; Earl S Ford; Stephen C Redd
Journal:  MMWR Surveill Summ       Date:  2002-08-02
View more
  4 in total

1.  Workplace asthma.

Authors:  Nick R Anthonisen
Journal:  Can Respir J       Date:  2008 Nov-Dec       Impact factor: 2.409

2.  Body composition changes in male patients with chronic obstructive pulmonary disease: Aging or disease process?

Authors:  Li-Wen Lee; Chieh-Mo Lin; Hung-Chou Li; Pei-Lin Hsiao; An-Chi Chung; Chu-Jung Hsieh; Pi-Chi Wu; Shu-Feng Hsu
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

Review 3.  Epidemiology of chronic obstructive pulmonary disease: a literature review.

Authors:  Catherine E Rycroft; Anne Heyes; Lee Lanza; Karin Becker
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-07-20

Review 4.  Global and regional estimates of COPD prevalence: Systematic review and meta-analysis.

Authors:  Davies Adeloye; Stephen Chua; Chinwei Lee; Catriona Basquill; Angeliki Papana; Evropi Theodoratou; Harish Nair; Danijela Gasevic; Devi Sridhar; Harry Campbell; Kit Yee Chan; Aziz Sheikh; Igor Rudan
Journal:  J Glob Health       Date:  2015-12       Impact factor: 7.664

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.